about
Double-stranded RNA-dependent protein kinase is required for bone calcification in MC3T3-E1 cells in vitroPreventive effect of Daiokanzoto (TJ-84) on 5-fluorouracil-induced human gingival cell death through the inhibition of reactive oxygen species productionPTEN expression elicited by EGR-1 transcription factor in calyculin A-induced apoptotic cells.Advanced glycation end-products and Porphyromonas gingivalis lipopolysaccharide increase calprotectin expression in human gingival epithelial cells.Oral Porphyromonas gingivalis translocates to the liver and regulates hepatic glycogen synthesis through the Akt/GSK-3β signaling pathway.Intermedilysin induces EGR-1 expression through calcineurin/NFAT pathway in human cholangiocellular carcinoma cells.High glucose levels increase osteopontin production and pathologic calcification in rat dental pulp tissues.Calcineurin regulates phosphorylation status of transcription factor osterix.PKR induces the expression of NLRP3 by regulating the NF-κB pathway in Porphyromonas gingivalis-infected osteoblasts.Okadaic acid induces apoptosis through double-stranded RNA-dependent protein kinase/eukaryotic initiation factor-2alpha pathway in human osteoblastic MG63 cells.Double-stranded RNA mediates selective gene silencing of protein phosphatase type 1 delta isoform in HEK-293 cells.Reduction of PP2A Cα stimulates adipogenesis by regulating the Wnt/GSK-3β/β-catenin pathway and PPARγ expression.Reduction of protein phosphatase 2A Cα enhances bone formation and osteoblast differentiation through the expression of bone-specific transcription factor Osterix.Calyculin A stimulates the expression of TNF-alpha mRNA via phosphorylation of Akt in mouse osteoblastic MC3T3-E1 cells.Expression of PTEN and Akt phosphorylation in lipopolysaccharide-treated NIH3T3 cells.Reduction of protein phosphatase 2A Cα promotes in vivo bone formation and adipocyte differentiation.Porphyromonas gingivalis attenuates the insulin-induced phosphorylation and translocation of forkhead box protein O1 in human hepatocytes
P50
Q24337935-50546335-6A5A-47D7-9190-1F76421D47DEQ34497892-22308406-457E-4C33-9819-D2AC3D2A63E1Q38334830-DDF04D15-36B8-4591-BBB3-22EA91147124Q38695799-B18A8A30-F08E-4EF9-B7F4-9A3FA4014AEBQ39117983-28D22D20-741F-48FD-9618-CC170E4DEE91Q39629291-9EC2437D-12C7-4ED5-AB8E-89C7DDEB581CQ39703084-2AF05FB3-C733-478B-807F-65ECE032579CQ39900805-AC1BCA36-3C2D-4B89-B57C-94B4ADADB0E9Q40279105-BF5D61D5-07C0-4EF2-8FB7-2C6C0E3DE3B8Q40476129-C6E082B1-597C-4878-849B-569C48211C3FQ40488839-5E74689B-F5DA-4775-A2D3-4FE1022481AAQ42800900-E9DEAD89-4E06-4F4E-A0D9-691E9C9A163FQ42809218-22902D14-B59A-41CF-8B84-84D29949F567Q42828591-3BD9D245-D6FD-49FC-BDD4-EF1749BCEEE1Q42834017-B414C5A1-0BF6-4C94-87C3-3C35717D6CCBQ47413183-A9F1CCB7-B59B-491D-9316-EBB95E51225AQ89262752-9AD9FE68-49DD-4194-9E40-9FA0D29C3FAE
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kaya Yoshida
@ast
Kaya Yoshida
@en
Kaya Yoshida
@es
Kaya Yoshida
@nl
type
label
Kaya Yoshida
@ast
Kaya Yoshida
@en
Kaya Yoshida
@es
Kaya Yoshida
@nl
prefLabel
Kaya Yoshida
@ast
Kaya Yoshida
@en
Kaya Yoshida
@es
Kaya Yoshida
@nl
P106
P1153
8982134600
P31
P496
0000-0002-3202-0634